Key Takeaways The GARP strategy identifies undervalued stocks with solid growth prospects for maximum returns.GARP combines value metrics like P/E ratios with growth rates between 10% and 25%.TPR, VRT, CLS and COR represent promising GARP opportunities with strong fundamentals. If you are looking for a profitable portfolio of stocks offering the best of value and growth investing, you can try the growth at a reasonable price or GARP strategy.
The strategy helps investors gain exposure to undervalued stocks with impressive prospects. Unlike a blend strategy, a portfolio that uses GARP investing is expected to include stocks that offer the best of value and growth investing. Tapestry (TPR - Free Report) , Vertiv (VRT - Free Report) , Celestica (CLS - Free Report) and Cencora (COR - Free Report) are some GARP stocks that hold promise.
GARP Metrics: Mix of Growth & Value MetricsThe GARP strategy seeks to offer an ideal investment by utilizing the best features of value and growth investing. Investors adopting the GARP approach prefer buying stocks priced below the market or any reasonable target determined by fundamental analysis. These stocks also have solid prospects in terms of cash flow, revenues, earnings per share (EPS) and so on.
Growth Metrics
A strong earnings growth history and impressive earnings prospects are the main concepts that GARP investors borrow from the growth investing strategy. However, instead of super-normal growth rates, pursuing stocks with a more stable and reasonable growth rate is a tactic of GARP investors. Hence, growth rates between 10% and 20% are considered ideal under the GARP strategy.
Another metric that growth and GARP investors consider is return on equity (ROE). GARP investors look for a strong and higher ROE than the industry average to identify superior stocks. Stocks with positive cash flows find precedence under the GARP plan.
Value Metrics
GARP investing prioritizes popular value metrics, the price-to-earnings (P/E) and price-to-book (P/B) ratios. Though this investing style picks stocks with higher P/E ratios than value investors, it avoids companies with extremely high P/E ratios.
Using the GARP principle, we ran a screen to identify stocks that should offer solid returns in the near term.
Screening ParametersAlong with the criteria discussed in the above section, we have considered a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today's Zacks #1 Rank stocks here.
Last 5-year EPS & projected 3-5-year EPS growth rates between 10% and 25% (Strong EPS growth history and prospects ensure improving business.)
ROE (over the past 12 months) greater than the industry average (Higher ROE than the industry average indicates superior stocks.)
P/E and P/B ratios less than the M-industry average (P/E and P/B ratios less than that of the industry indicate that the stocks are undervalued)
Here are four stocks from the six that made it through the screening process.
Tapestry raised its full-year fiscal 2026 revenue outlook to approximately $7.95 billion and its operating margin outlook to 23%, citing third-quarter outperformance and an improved fourth-quarter view, with Coach continuing to lead pro forma growth. The April 2026 board appointment of Pinterest's chief technology officer strengthened Tapestry's digital growth strategy.
Reinforcing confidence in cash generation, its board increased planned shareholder returns for the fiscal year and declared a quarterly dividend payable in June 2026. Together, these developments point to durable brand momentum, disciplined execution and strengthening fundamentals that support Tapestry's near-term trajectory.
The Zacks Consensus Estimate for Tapestry’s fiscal 2026 earnings has moved north by 7.8% to $6.95 per share in the past 60 days. This Zacks Rank #1 company surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 15.59%.
Vertiv is set to enter the second half of 2026 on a stronger fundamental footing. After raising full-year 2026 guidance in April to net sales of $13.5-$14 billion, organic growth of 29-31% and adjusted EPS of $6.30-$6.40, management used its May investor conference to lift long-term targets further. The company raised its 2030 adjusted operating margin goal to roughly 27%-plus and organic growth CAGR to 20-22%, while expanding planned capital deployment to about $28 billion through 2030. The company also widened its thermal-chain portfolio through April's Strategic Thermal Labs acquisition and June's completed ThermoKey deal, adding liquid-cooling and heat-rejection capabilities for AI data centers. This month also saw a NVIDIA Omniverse DSX digital-twin integration and a new water-reduction fluid service alongside a steady quarterly dividend, supporting shareholders.
The Zacks Consensus Estimate for VRT’s 2026 earnings has moved north by 5.6% to $6.36 per share in the past 60 days. This Zacks Rank #2 company surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 14.65%.
Celestica is likely to be on a solid footing in the near term. The company’s first-quarter revenues were $4.05 billion, up 53% year over year, with adjusted operating margin reaching a record 8.0%. Management responded by raising its full-year 2026 outlook to $19.0 billion for revenues and $10.15 for adjusted earnings per share, citing accelerating Connectivity & Cloud Solutions demand and improving 2027 visibility. Days later, Celestica unveiled its DS6000-series 1.6TbE switches, strengthening its AI networking portfolio for hyperscale customers. In May, the company announced a major Fort Worth, TX manufacturing expansion exceeding one million square feet, which added roughly 1,700 jobs to support surging AI infrastructure demand. An upsized $2.5 billion credit facility reinforces liquidity, positioning Celestica favorably for continued growth.
The consensus estimate for this Zacks Rank #2 company’s 2026 earnings has moved north by 13.6% to $10.16 per share in the past 60 days. Its earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 8.01%.
Cencora enters the second half of fiscal 2026 on a solid fundamental footing. Second-quarter revenues rose to $78.4 billion, with adjusted EPS growing 7.5% year over year. This prompted an upward revision to full-year adjusted EPS guidance, which was later raised again to $17.7–$17.9. The company authorized a new $2 billion buyback program. In April, the divestiture of non-core U.S. hub consulting operations sharpened focus on higher-margin specialty and core distribution businesses. May also brought a smooth CFO leadership transition alongside reaffirmed long-term targets for adjusted operating income and EPS growth. In June, a new agreement supporting U.S. distribution of Kite's CAR T-cell therapies, Yescarta and Tecartus, extends Cencora's specialty distribution footprint further, reinforcing diversified, durable growth momentum into the fiscal year-end.
The consensus estimate for this Zacks Rank #2 company’s fiscal 2026 earnings has moved north by 0.8% to $17.72 per share in the past 60 days. The company surpassed the Zacks Consensus Estimate in three of the trailing four quarters, while missing once, the average surprise being 1.59%.
Key Takeaways Rising P/E ratios often signal investor confidence, earnings strength and further upside potential. The screen identifies stocks with accelerating earnings growth and sustained price momentum. DLTR, SFIX, AIM, COR and ISRG pair rising P/Es with strong earnings performance. Investors often opt for an investment approach that involves picking stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio is, the higher the stock value. The reasoning behind this is straightforward — when a stock's current market price does not adequately reflect its higher earnings, it suggests potential for growth.
But there is more to this whole P/E story. Because not only low P/E, stocks with a rising P/E can also fetch strong returns. In this regard, investors can bet on the likes of Dollar Tree (DLTR - Free Report) , Stitch Fix (SFIX - Free Report) , AIM ImmunoTech (AIM - Free Report) , Cencora Inc. (COR - Free Report) and Intuitive Surgical (ISRG - Free Report) .
Rising P/E: A Useful ToolThe concept is that as earnings rise, so should the price of the stock. As forecasts for expected earnings come in higher, strong demand for the stock should continue to push up its prices. After all, a stock's P/E gives an indication of how much investors are ready to shell out per dollar of earnings.
Suppose an investor wants to buy a stock with a P/E ratio of 30. This means that he is willing to shell out $30 for only $1 worth of earnings as he expects earnings of the company to rise at a faster pace in the future owing to strong fundamentals.
So, if the P/E of a stock is rising steadily, it means that investors are assured of its inherent strength and expect some strong positives out of it.
Also, studies have revealed that stocks have seen their P/E ratios jump over 100% from their breakout point in the cycle. So, if you can pick stocks early in their breakout cycle, you can end up seeing considerable gains.
Winning StrategyIn order to shortlist stocks that are exhibiting an increasing P/E, we chose the following as our primary screening parameters.
EPS growth estimate for the current year is greater than or equal to last year’s actual growth
Percentage change in last year EPS should be greater than or equal zero
(These two criteria point to flat earnings or a growth trend over the years.)
Percentage change in price over four weeks greater than the percentage change in price over 12 weeks
Percentage change in price over 12 weeks greater than percentage change in price over 24 weeks
(These two criteria show that price of the stock is increasing consistently over the said timeframes.)
Percentage price change for four weeks relative to the S&P 500 greater than the percentage price change for 12 weeks relative to the S&P 500
Percentage price change for 12 weeks relative to the S&P 500 greater than the percentage price change for 24 weeks relative to the S&P 500
(Here, the case for consistent price gains gets even stronger as it displays percentage price changes relative to the S&P 500.)
Percentage price change for 12 weeks is 20% higher than or equal to the percentage price change for 24 weeks, but it should not exceed 100%
(A 20% increase in the price of a stock from the breakout point gives cues of an impending uptrend. But a jump of over 100% indicates that there is limited scope for further upside and that the stock might be due for a reversal.)
In addition, we place a few other criteria that lead us to some likely outperformers.
Zacks Rank less than or equal to 2: Only companies with a Zacks Rank #1 (Strong Buy) or 2 (Buy) can get through.
Average 20-day Volume greater than or equal to 50,000: High trading volume implies that the stocks have adequate liquidity.
Just these few criteria narrowed down the universe from over 7,700 stocks to just 55.
Here are five out of the 55 stocks:
Dollar Tree: The Zacks Rank #2 company is an operator of discount variety stores offering merchandise and other assortments. You can see the complete list of today’s Zacks #1 Rank stocks here.
The average four-quarter earnings surprise of DLTR is 32.14%.
Stitch Fix: The Zacks Rank #2 company began with women’s apparel, expanded into men’s clothing in 2016, added plus sizes to the women’s category in 2017, and now offers a Kid’s category as well.
The average four-quarter earnings surprise of SFIX is 47.37%.
AIM ImmunoTech: It is an immuno-pharma company with a Zacks Rank #2.
The average four-quarter earnings surprise of AIM is 52.66%.
Cencora: The Zacks Rank #2 company is one of the largest pharmaceutical distribution and healthcare solution providers globally.
The average four-quarter earnings surprise of COR is 1.59%.
Intuitive Surgical: The Zacks Rank #2 company designs, manufactures and markets the da Vinci surgical system, Ion endoluminal system and related instruments and accessories.
The average four-quarter earnings surprise of ISRG is 16.82%.
Key Takeaways Cencora launched an upgraded Nucleus inventory solution for specialty physician practices.The platform aims to improve workflow efficiency, inventory visibility and provider control.Cencora is piloting Nucleus at over 20 sites before potential production scaling this year. Cencora (COR - Free Report) recently announced the launch of the next-generation Nucleus inventory management solution and initiated a multi-site pilot across more than 20 specialty physician practice locations. The enhanced platform is designed to help providers manage increasingly complex medication workflows with greater efficiency, visibility and control.
From an investor's perspective, the launch underscores Cencora's continued investments in technology-enabled specialty solutions and strengthens its value proposition within the fast-growing specialty pharmaceutical market. If successfully scaled, the enhanced Nucleus platform could deepen customer relationships, improve service differentiation and support long-term growth in the company's specialty distribution and solutions business.
Likely Trend of COR Stock Following the NewsShares of COR have traded flat since the announcement of the news. In the year-to-date period, shares of the company have lost 18% compared with the industry’s 6.5% decline. The S&P 500 increased 10% in the same time frame.
The launch of the enhanced Nucleus platform is likely to strengthen Cencora's long-term growth prospects by deepening its integration with specialty physician practices and expanding its technology-enabled service offerings. By helping providers improve inventory management, workflow efficiency and data visibility, the solution can increase customer retention and attract new specialty care clients. The broader deployment of Nucleus also positions Cencora to capitalize on the growing complexity of specialty therapies and reinforces its competitive standing in the higher-margin specialty distribution and solutions market.
COR currently has a market capitalization of $54.8 million.
Image Source: Zacks Investment Research
More on the NewsThe next-generation Nucleus solution was co-developed with specialty care providers and customer advisory boards to address the growing complexity of medication management in specialty physician practices. The enhanced platform combines redesigned physical infrastructure with software and interface upgrades to provide greater efficiency, visibility and control over inventory workflows.
The platform features a modular cabinet design that can be configured to support varying practice needs, a larger integrated touchscreen for improved access to patient and inventory data and built-in workspace enhancements that streamline the handling of physical inventory. It also includes a more unified interface aimed at reducing complexity, shortening training time and improving consistency for both clinical and administrative teams.
The upgraded Nucleus platform builds on its existing capabilities, which include real-time inventory tracking, demand forecasting, automated billing support and a robust suite of reporting tools that help practices monitor costs, utilization and operational performance. The solution is designed to improve visibility into inventory and patient-specific medication requirements while supporting more coordinated workflows spanning ordering, tracking, storage and administration.
Cencora has launched a multi-site pilot across more than 20 practice locations to evaluate system performance in diverse care settings and gather customer feedback. Subject to favorable pilot outcomes, the company expects to scale production and installation later this year and subsequently expand the platform's availability to both existing and new customers.
Favorable Industry Prospect for CORPer a report by Growth Market Reports, the specialty pharmaceuticals market size was valued at $16.37 billion in 2025 and estimated to grow from $22.12 billion in 2026 to reach $99.63 billion by 2031, at a CAGR of 35.12%.
Growth in the specialty pharmaceuticals market is being driven by the rising prevalence of chronic and complex diseases, including cancer, autoimmune disorders and rare diseases, alongside increasing adoption of biologics and precision medicines.
A Recent Development by CORRecently, Cencora announced an agreement with Kite, a Gilead company, to support the U.S. distribution of its FDA-approved CAR T-cell therapies, Yescarta and Tecartus. The collaboration aims to facilitate efficient access to these cell therapies across a growing network of authorized treatment centers in the United States, including health systems and community oncology practices, thereby strengthening Cencora's presence in the rapidly expanding cell and gene therapy distribution market.
COR’s Zacks Rank & Other Key PicksCurrently, COR carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , West Pharmaceutical (WST - Free Report) and Intuitive Surgical (ISRG - Free Report) .
Globus Medical, currently flaunting a Zacks Rank #1 (Strong Buy), reported a first-quarter 2026 adjusted earnings per share (EPS) of $1.12 per share, which surpassed the Zacks Consensus Estimate by 22.1%. Revenues of $759.9 million beat the Zacks Consensus Estimate by 4.0%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GMED has an estimated long-term earnings growth rate of 10.2% compared with the industry’s 12.6% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 26.3%.
West Pharmaceutical, currently sporting a Zacks Rank #1, reported first-quarter 2026 EPS of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%.
WST has an estimated long-term earnings growth rate of 13.9% compared with the industry’s 9.5% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 19.4%.
Intuitive Surgical, carrying a Zacks Rank #2 at present, reported first-quarter 2026 adjusted EPS of $2.50, which beat the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%.
ISRG has a long-term estimated growth rate of 14.6% compared with the industry’s 12.6% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.
Have you been paying attention to shares of Life Time Group Holdings, Inc. (LTH - Free Report) ? Shares have been on the move with the stock up 6.4% over the past month. The stock hit a new 52-week high of $35.33 in the previous session. Life Time Group Holdings has gained 31.2% since the start of the year compared to the -8.3% move for the Zacks Consumer Discretionary sector and the -0.4% return for the Zacks Leisure and Recreation Services industry.
What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on May 5, 2026, Life Time Group Holdings reported EPS of $0.42 versus consensus estimate of $0.39 while it beat the consensus revenue estimate by 0.09%.
For the current fiscal year, Life Time Group Holdings is expected to post earnings of $1.66 per share on $3.33 in revenues. This represents a 15.28% change in EPS on a 11.19% change in revenues. For the next fiscal year, the company is expected to earn $1.88 per share on $3.72 in revenues. This represents a year-over-year change of 12.83% and 11.65%, respectively.
Valuation MetricsWhile Life Time Group Holdings has moved to its 52-week high over the past few weeks, investors need to be asking, what is next for the company? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.
On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.
Life Time Group Holdings has a Value Score of B. The stock's Growth and Momentum Scores are C and B, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 21X current fiscal year EPS estimates, which is a premium to the peer industry average of 16.3X. On a trailing cash flow basis, the stock currently trades at 13.2X versus its peer group's average of 8.8X. Additionally, the stock has a PEG ratio of 1.28. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.
Zacks RankWe also need to consider the stock's Zacks Rank, as this is even more important than the company's VGM Score. Fortunately, Life Time Group Holdings currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Life Time Group Holdings meets the list of requirements. Thus, it seems as though Life Time Group Holdings shares could still be poised for more gains ahead.
Investors interested in Leisure and Recreation Services stocks are likely familiar with Life Time Group Holdings, Inc. (LTH) and Viking Holdings (VIK). But which of these two stocks presents investors with the better value opportunity right now?
Tenet Healthcare (THC - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this hospital operator have returned -4.8%, compared to the Zacks S&P 500 composite's +0.3% change. During this period, the Zacks Medical - Hospital industry, which Tenet falls in, has lost 11.4%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Tenet is expected to post earnings of $4.08 per share for the current quarter, representing a year-over-year change of +1.5%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.7%.
The consensus earnings estimate of $17.61 for the current fiscal year indicates a year-over-year change of +5%. This estimate has changed +0.2% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $17.63 indicates a change of +0.2% from what Tenet is expected to report a year ago. Over the past month, the estimate has remained unchanged.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Tenet.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For Tenet, the consensus sales estimate for the current quarter of $5.39 billion indicates a year-over-year change of +2.3%. For the current and next fiscal years, $22.02 billion and $22.43 billion estimates indicate +3.3% and +1.9% changes, respectively.
Last Reported Results and Surprise HistoryTenet reported revenues of $5.37 billion in the last reported quarter, representing a year-over-year change of +2.8%. EPS of $4.82 for the same period compares with $4.36 a year ago.
Compared to the Zacks Consensus Estimate of $5.39 billion, the reported revenues represent a surprise of -0.36%. The EPS surprise was +14.49%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Tenet is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Tenet. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.
Tenet Healthcare (THC - Free Report) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.
A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.
Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.
As such, the Zacks rating upgrade for Tenet is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Tenet imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for TenetFor the fiscal year ending December 2026, this hospital operator is expected to earn $17.61 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for Tenet. Over the past three months, the Zacks Consensus Estimate for the company has increased 1.8%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Tenet to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Investors looking for stocks in the Manufacturing - Electronics sector might want to consider either Vestas Wind Systems AS (VWDRY - Free Report) or Eaton (ETN - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.
Currently, Vestas Wind Systems AS has a Zacks Rank of #2 (Buy), while Eaton has a Zacks Rank of #3 (Hold). This means that VWDRY's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is only part of the picture for value investors.
Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.
The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors.
VWDRY currently has a forward P/E ratio of 19.60, while ETN has a forward P/E of 30.60. We also note that VWDRY has a PEG ratio of 1.31. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. ETN currently has a PEG ratio of 2.62.
Another notable valuation metric for VWDRY is its P/B ratio of 5.76. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, ETN has a P/B of 8.01.
Based on these metrics and many more, VWDRY holds a Value grade of B, while ETN has a Value grade of D.
VWDRY stands above ETN thanks to its solid earnings outlook, and based on these valuation figures, we also feel that VWDRY is the superior value option right now.
Eaton (ETN - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this power management company have returned +7.9%, compared to the Zacks S&P 500 composite's +0.3% change. During this period, the Zacks Manufacturing - Electronics industry, which Eaton falls in, has gained 5.1%. The key question now is: What could be the stock's future direction?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Eaton is expected to post earnings of $3.07 per share for the current quarter, representing a year-over-year change of +4.1%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.1%.
For the current fiscal year, the consensus earnings estimate of $13.33 points to a change of +10.4% from the prior year. Over the last 30 days, this estimate has remained unchanged.
For the next fiscal year, the consensus earnings estimate of $15.64 indicates a change of +17.4% from what Eaton is expected to report a year ago. Over the past month, the estimate has remained unchanged.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Eaton.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
In the case of Eaton, the consensus sales estimate of $8 billion for the current quarter points to a year-over-year change of +13.9%. The $31.8 billion and $35.07 billion estimates for the current and next fiscal years indicate changes of +15.8% and +10.3%, respectively.
Last Reported Results and Surprise HistoryEaton reported revenues of $7.45 billion in the last reported quarter, representing a year-over-year change of +16.8%. EPS of $2.81 for the same period compares with $2.72 a year ago.
Compared to the Zacks Consensus Estimate of $7.09 billion, the reported revenues represent a surprise of +5.16%. The EPS surprise was +2.55%.
Over the last four quarters, Eaton surpassed consensus EPS estimates three times. The company topped consensus revenue estimates two times over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Eaton is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Eaton. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
In the latest trading session, Eaton (ETN - Free Report) closed at $421.77, marking a +2.96% move from the previous day. The stock outpaced the S&P 500's daily gain of 1.09%. Meanwhile, the Dow experienced a rise of 0.14%, and the technology-dominated Nasdaq saw an increase of 1.91%.
Shares of the power management company have appreciated by 7.89% over the course of the past month, outperforming the Industrial Products sector's gain of 5.53%, and the S&P 500's gain of 0.29%.
The investment community will be closely monitoring the performance of Eaton in its forthcoming earnings report. The company's upcoming EPS is projected at $3.07, signifying a 4.07% increase compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $8 billion, indicating a 13.88% increase compared to the same quarter of the previous year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $13.33 per share and a revenue of $31.8 billion, representing changes of +10.44% and +15.84%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Eaton. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.03% lower within the past month. At present, Eaton boasts a Zacks Rank of #3 (Hold).
Looking at valuation, Eaton is presently trading at a Forward P/E ratio of 30.74. This expresses a premium compared to the average Forward P/E of 22.94 of its industry.
It's also important to note that ETN currently trades at a PEG ratio of 2.63. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Manufacturing - Electronics stocks are, on average, holding a PEG ratio of 1.8 based on yesterday's closing prices.
The Manufacturing - Electronics industry is part of the Industrial Products sector. This industry currently has a Zacks Industry Rank of 84, which puts it in the top 35% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Key Takeaways Rockwell has an edge over Eaton, supported by positive analyst sentiment and stronger price performance.Eaton benefits from data center demand, R&D investments, acquisitions and broad end-market exposure.Rockwell's recurring revenues, pricing actions, product expansion and growth investments support demand. Rising investments in automation, artificial intelligence, industrial software, robotics and digital infrastructure are driving industrial tech stocks like Eaton Corporation (ETN - Free Report) and Rockwell Automation (ROK - Free Report) .
Eaton is a diversified power management company and a global technology leader in electrical components and systems, while Rockwell Automation is the world’s largest company dedicated to industrial automation and digital transformation.
Expanding demand for electrification, data centers and advanced manufacturing is opening up significant new avenues for growth across the industry. As businesses continue to modernize their operations and embrace next-generation technologies, companies with solid recurring revenue models, innovative product offerings and exposure to long-term digital transformation trends are well-positioned to capitalize on these opportunities.
For long-term investors, which stock offers the more compelling opportunity? Let’s take a closer look at both companies' fundamentals.
Factors to Consider for ETNEaton is well-positioned to benefit from several long-term growth drivers, including grid modernization, data center expansion, industrial automation, energy transition, and the recovery of aerospace markets. Its strong and growing backlog reflects healthy customer demand and underscores the company's ability to provide mission-critical power management solutions across diverse end markets.
The company has articulated a clear growth strategy focused on innovation and sustainability. Over the next decade, Eaton plans to invest approximately $3 billion in research and development to create advanced, energy-efficient technologies and sustainable solutions. These investments are intended to address evolving customer needs, strengthen existing product offerings and reinforce the company’s competitive position across global markets.
Eaton is also expanding its growth platform through strategic acquisitions. During the first quarter, the company completed nearly $11 billion in acquisitions aimed at increasing its presence in attractive, high-growth and high-margin markets. These transactions are expected to enhance Eaton’s long-term earnings potential and support sustained value creation.
The rapid growth of AI-driven data centers presents a significant opportunity for Eaton, as these facilities require substantially greater power capacity and energy density. The company is expanding its participation across the electrical power value chain while benefiting from strong demand in both data center and utility markets. It is also seeing continued momentum in commercial aerospace and defense. Furthermore, Eaton’s diversified exposure across commercial, industrial, utility, aerospace, and residential markets reduces dependence on any single industry or customer base.
In addition, Eaton remains focused on improving operational performance through productivity initiatives, portfolio optimization and disciplined integration of acquisitions. These efforts, combined with a favorable end-market backdrop and continued investment in innovation, position the company to drive margin expansion, strengthen its competitive advantages and deliver sustainable long-term growth.
Return on equity is 24.72%, ahead of the industry average of 20.35%. ETN has gained 18.2% in the past three months.
Factors to Consider for ROKRockwell Automation is poised to benefit from long-term growth drivers such as factory automation, manufacturing reshoring, industrial digitization, and the increasing adoption of smart manufacturing solutions. Its competitive advantage stems from a broad portfolio of automation hardware, software, and services, anchored by the market-leading Allen-Bradley control systems and FactoryTalk software platform.
The company is a key enabler of Industry 4.0, helping manufacturers build connected, intelligent factories where machines, systems, and employees interact seamlessly in real time. Growing investments in Industrial Internet of Things (IIoT), artificial intelligence and advanced analytics are driving demand for Rockwell’s solutions. Strategic alliances with Microsoft, PTC and NVIDIA further strengthen its digital capabilities and expand its reach beyond traditional automation markets.
Rockwell is also benefiting from rising capital investments across attractive end markets, including life sciences, electric vehicles, battery manufacturing, semiconductors, food and beverage, and logistics automation. In addition, government-backed initiatives promoting domestic manufacturing in North America and Europe are supporting demand for modern production facilities and automation technologies.
Management recently increased its fiscal 2026 sales and earnings outlook, reflecting stronger demand, productivity improvements and pricing actions that are expected to offset inflationary and tariff-related pressures. The company has enhanced its software and recurring revenue mix through acquisitions such as Plex, which expanded its cloud-based manufacturing software capabilities, and CUBIC, which strengthened its electrical systems and intelligent motor control offerings. The exit from the underperforming Sensia joint venture has further streamlined the portfolio.
Rockwell’s planned $2 billion investment in manufacturing capacity, digital infrastructure, and workforce development should enhance operational resilience and support future growth. Supported by strong cash generation, expanding software and services revenues, and a disciplined capital allocation strategy that includes dividends and share repurchases, Rockwell remains well-positioned to create long-term shareholder value.
ROK’s return on equity of 37.5% lags the industry average. ROK shares have gained 33.4% in the past three months.
Estimates for ETN and ROKThe Zacks Consensus Estimate for ETN’s 2026 revenues implies a year-over-year increase of 15.8%, while that for EPS implies a year-over-year increase of 10.4%. EPS estimates witnessed no movement in the past 30 days. The expected long-term earnings growth rate is pegged at 11.7%. The company has a Growth Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for ROK’s 2026 revenues implies a year-over-year increase of 7.4%, and that for EPS implies a year-over-year increase of 22.2%. EPS estimates have moved 1% north in the past 30 days. The expected long-term earnings growth rate is pegged at 12%. The company has a Growth Score of B.
Image Source: Zacks Investment Research
Are ETN and ROK Shares Expensive?Eaton is trading at a forward 12-month price to earnings of 29.28X, above the median of 26.41X over the last three years.
Rockwell is trading at a forward 12-month price to earnings of 33.83X, above the median of 26.45X over the last three years.
Rockwell shares are more expensive than Eaton's.
Image Source: Zacks Investment Research
ConclusionEaton continues to deliver strong performance across its core businesses while benefiting from rising demand tied to data center expansion. Focusing on research and development supports innovation, improves its product portfolio, and enables it to better meet changing customer requirements. Additionally, strategic acquisitions are enhancing Eaton’s capabilities, broadening its product offerings, and increasing its reach across attractive growth markets.
Rockwell Automation is seeing steady demand across discrete, hybrid and process markets, supported by its diversified portfolio. The company will benefit from recent wins across diverse end markets, rising recurring revenues, pricing discipline, expanding portfolio of products, growth investments and acquisitions.
Rockwell carries a Zacks Rank #2 (Buy), while Eaton carries a Zacks Rank #3 (Hold). Given positive analyst sentiment and price performance, Rockwell has an edge over Eaton.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
F5 AI Guardrails and Equinix Distributed AI Hub combine to enable distributed enterprise AI deployments with speed, flexibility, and security
SEATTLE--(BUSINESS WIRE)--F5 (NASDAQ: FFIV), the global leader in delivering and securing every app and API, today announced a collaboration with Equinix, the world’s digital infrastructure company, to help enterprises deploy and govern distributed AI securely across hybrid and multicloud environments. It combines F5 AI Guardrails with the Equinix Distributed AI Hub, Equinix’s single, unified framework for enterprises to connect, secure, and simplify their increasingly complex and distributed AI ecosystems. The result is a policy-enforced AI control plane where distributed AI traffic runs over private interconnects, and every AI interaction is designed to be governed by consistent, audit-ready guardrails across clouds, models, and agents.
Agentic and generative AI are rapidly increasing enterprise connectivity and expanding the security perimeter from users to agents. Organizations are connecting multiple agents to multiple models, multiple clouds, and multiple data sources, creating new security gaps, governance complexity, shadow AI concerns, and compliance risk. At the same time, many enterprises are building AI systems and agentic workflows in isolation, leading to fragmented architectures, inconsistent controls, vendor and data lock-in, rising infrastructure and data egress costs, and growing AI spend sprawl. Traditional application security tools were not designed for AI-native traffic and often miss AI-specific risks during interactions—such as prompt injection, data leakage, model misbehavior, and harmful outputs—limiting observability and making governance and audit readiness difficult.
F5 and Equinix address these challenges directly, giving enterprises a comprehensive foundation for deploying secure, flexible, and efficient distributed AI systems without refactoring architectures or sacrificing sovereignty. The architecture provides a consistent control plane for coordinating AI interactions across distributed models, agents, data sources, and cloud environments, helping organizations scale AI without introducing operational fragmentation or governance gaps.
A vendor-neutral AI fabric with built-in security and governance
The Equinix Distributed AI Hub is a neutral location that allows enterprises to discover, connect to, and consume AI infrastructure providers—including model companies, GPU clouds, data platforms, network and security services, and AI frameworks—all through Equinix’s global ecosystem of more than 280 interconnected data centers and 10,000-plus customers. This enables enterprises to run their distributed AI across clouds without vendor lock-in or infrastructure re-engineering. F5 AI Guardrails applies AI-native, policy-based controls during AI interactions to detect and block data leakage, policy violations, and harmful outputs, with centralized visibility and audit-ready traceability.
The combined framework enables enterprises to:
Deploy distributed AI faster across Equinix’s vendor-neutral and interconnected ecosystem of 280+ data centers with direct, private access to clouds, data platforms, models, AI providers, and partners Detect and prevent sensitive data from leaving controlled environments, and block noncompliant outputs with moderation controls that adapt as new models and business needs emerge Enforce consistent governance frameworks with centralized visibility; unified dashboards across models, agents, and users; and audit-ready reporting aligned to regulations such as GDPR, HIPAA, and the EU AI Act Operate AI securely across hybrid and multicloud environments with consistent, model-agnostic guardrails and flexible deployment options that meet data privacy and sovereignty requirements with latency suitable for interactive workloads It combines Equinix’s distributed infrastructure and ecosystem connectivity with F5’s AI-native protections into a unified control plane that governs AI interactions across every cloud, model, and agent an enterprise uses. Additionally, F5’s AI Guardrails is deployed as an on‑prem solution within Equinix, making it well suited for organizations with strict regulatory and data sovereignty requirements. For organizations navigating multi-model, multicloud complexity under growing regulatory pressure, this is the difference between distributed AI that introduces risk and distributed AI that is governed by design.
“Enterprises want to move fast with AI, but security gaps, fragmented governance, and compliance uncertainty keep slowing them down,” said John Maddison, Chief Marketing Officer, F5. “Together with Equinix, we are giving organizations a way to deploy distributed AI across hybrid and multicloud environments with the speed and flexibility they need, while ensuring every AI interaction is protected, governed, and audit-ready. This is about making secure AI adoption the path of least resistance, not the bottleneck.”
“Enterprises require infrastructure that supports AI innovation without forcing tradeoffs between performance, security, or control,” said Brian Stein, Senior Vice President of Infrastructure, Equinix. “Equinix is the neutral platform where AI, cloud, and networking infrastructure converge. By combining F5 AI Guardrails with the Equinix Distributed AI Hub, we offer customers a simpler and smarter vendor-neutral foundation to build and scale distributed AI with confidence.”
Built for today’s most pressing enterprise challenges
The combined framework supports critical use cases across industries, including preventing sensitive data leakage to LLMs with policy-based controls and audit-ready logs, centralizing governance across distributed AI deployments for consistent policies and visibility, protecting against model misbehavior and harmful outputs, gaining control over shadow AI to manage risk and cost, and supporting data privacy and sovereignty requirements by aligning where AI runs and where data lives. In addition, F5 AI Red Team can further strengthen security posture by surfacing exploitable weaknesses against guardrail policies.
To learn more about the F5 and Equinix partnership, collaborations, and how to get started, visit: https://www.f5.com/equinix
Additional resources
Solution guide: F5 AI Guardrails for Equinix Distributed AI Hub Blog: How F5 and Equinix help secure and govern distributed AI About F5
F5, Inc. (NASDAQ: FFIV) is the global leader that delivers and secures every app. Backed by three decades of expertise, F5 has built the industry’s premier platform—F5 Application Delivery and Security Platform (ADSP)—to deliver and secure every app, every API, anywhere: on-premises, in the cloud, at the edge, and across hybrid, multicloud environments. F5 is committed to innovating and partnering with the world’s largest and most advanced organizations to deliver fast, available, and secure digital experiences. Together, we help each other thrive and bring a better digital world to life.
For more information visit f5.com
Explore F5 Labs threat research at f5.com/labs
Follow to learn more about F5, our partners, and technologies: Blog | LinkedIn | X | YouTube | Instagram | Facebook
F5 is a trademark, service mark, or tradename of F5, Inc., in the U.S. and other countries. All other product and company names herein may be trademarks of their respective owners. The use of the terms “partner,” “partners,” “partnership,” “partnering,” “collaboration,” “collaborate,” or “collaborates” in this press release does not imply that a joint venture exists between F5 and any other company.
Key Takeaways Equinix expanded Cisco and NVIDIA partnerships to accelerate enterprise AI adoption globally.EQIX will host Presidio's P.A.T.H. Lab to test, validate, and optimize AI infrastructure.Equinix data centers provide power, cooling, and interconnection for Cisco Secure AI Factory with NVIDIA. Equinix, Inc. (EQIX - Free Report) has expanded its partnership with Cisco and NVIDIA to speed enterprise AI adoption. Together with these partners, the company will enable customers to deploy the Cisco Secure AI Factory with NVIDIA across its global network of high-performance data centers, offering customers standardized AI factory blueprints and automated deployment capabilities.
Equinix is also teaming up with Presidio, a leading global technology services and solutions provider, to deploy its Programmable AI Technology Hub (“P.A.T.H.”) Lab. Located within Equinix data centers, the lab will provide customers with a real-world environment to test, validate and optimize AI infrastructure before rolling it out enterprise-wide.
By integrating Cisco Secure AI Factory with NVIDIA into its global data centers, Equinix gives customers access to the interconnection density, specialized power, and advanced cooling required to deploy the latest AI hardware and software. The deployments are based on NVIDIA reference architectures, allowing enterprises to purchase and implement technology through trusted partners and across existing platforms.
Built on Cisco’s Secure AI Factory with NVIDIA, the P.A.T.H. lab is a fully integrated, production-grade AI environment where enterprises can test, validate and refine their AI strategies before committing to full-scale rollouts.
Leveraging the combined expertise of Presidio, Cisco, NVIDIA and Equinix, enterprises gain access to turnkey AI infrastructure proven to work across hybrid workloads. The solution supports deployments spanning public cloud, neocloud, on-premises and colocation environments, enabling organizations to adopt AI solutions with confidence.
ConclusionAs enterprises accelerate AI adoption, demand is expanding beyond AI chips to the infrastructure required to deploy AI workloads efficiently and securely. Through its collaborations with Cisco, NVIDIA and Presidio, Equinix is positioning itself as a one-stop platform where customers can build, test and scale AI deployments. This strategy not only enhances the value of the company’s global data center footprint but also creates additional opportunities to drive long-term customer growth and recurring revenues.
In the past three months, shares of this Zacks Rank #2 (Buy) company have gained 12.5% compared with the industry's 7.6% growth.
Image Source: Zacks Investment Research
Other Stocks to ConsiderSome other top-ranked stocks from the broader REIT sector are Cousins Properties (CUZ - Free Report) and Vornado Realty Trust (VNO - Free Report) , each carrying a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for CUZ’s 2026 FFO per share is pegged at $2.93, which indicates year-over-year growth of 3.17%.
The Zacks Consensus Estimate for VNO’s full-year FFO per share is pinned at $2.34, which calls for an increase of 0.86% from the year-ago period.
Note: Anything related to earnings presented in this write-up represents FFO, a widely used metric to gauge the performance of REITs.
Trane Technologies (TT - Free Report) closed at $483.40 in the latest trading session, marking a +2.3% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 1.09% for the day. Elsewhere, the Dow saw an upswing of 0.14%, while the tech-heavy Nasdaq appreciated by 1.91%.
Coming into today, shares of the manufacturer had gained 4.61% in the past month. In that same time, the Business Services sector lost 1.18%, while the S&P 500 gained 0.29%.
Market participants will be closely following the financial results of Trane Technologies in its upcoming release. On that day, Trane Technologies is projected to report earnings of $4.27 per share, which would represent year-over-year growth of 10.05%. At the same time, our most recent consensus estimate is projecting a revenue of $6.16 billion, reflecting a 7.22% rise from the equivalent quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $14.83 per share and revenue of $23.25 billion, indicating changes of +13.55% and +9.05%, respectively, compared to the previous year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Trane Technologies. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, there's been a 0.16% fall in the Zacks Consensus EPS estimate. As of now, Trane Technologies holds a Zacks Rank of #3 (Hold).
In the context of valuation, Trane Technologies is at present trading with a Forward P/E ratio of 31.86. For comparison, its industry has an average Forward P/E of 15.73, which means Trane Technologies is trading at a premium to the group.
We can additionally observe that TT currently boasts a PEG ratio of 2.18. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Technology Services industry had an average PEG ratio of 1.42 as trading concluded yesterday.
The Technology Services industry is part of the Business Services sector. This group has a Zacks Industry Rank of 173, putting it in the bottom 30% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow TT in the coming trading sessions, be sure to utilize Zacks.com.
On June 17, 2026, we present a DCF analysis for AutoZone Inc AZO , a company that has experienced a challenging price performance recently, with a year-to-date decline of 7.8% and a one-year drop of 13.2%. Below are key highlights from our analysis:
DCF Earnings-based intrinsic value of $3817.47 per share compared to the current price of $3127.79, indicating a margin of safety of 18.1%. DCF FCF-based intrinsic value of $2184.44 per share suggests a modestly overvalued status with a margin of safety of -43.2%. GF Score™ of 93/100 indicates strong reliability of the DCF inputs, suggesting solid financial health and performance potential. What Is AZO Worth? DCF Earnings-Based Model The DCF earnings-based model for AutoZone Inc AZO utilizes a two-stage approach to estimate the intrinsic value of the stock. The first stage reflects a high growth phase, while the second stage accounts for a more stable growth period.
Parameter Value Current EPS (TTM, excl. non-recurring) $145.45 10-Year Growth Rate 17.4% 10-Year Treasury Rate 4.43% Discount Rate (ceil(Treasury) + 6%) 11% Terminal Growth Rate 4% In the first stage, we assume that EPS will grow at a rate of 17.4% per year for the next 10 years, discounted at a rate of 11%. The second stage assumes a terminal growth rate of 4% for the following 10 years, also discounted at 11%. Below is a summary of the calculations:
Stage Description Value Growth Stage (Years 1-10) EPS growing at 17.4%, discounted at 11% $2005.52 Terminal Stage (Years 11-20) 4% terminal growth, discounted at 11% $1811.95 Intrinsic Value Growth + Terminal $3817.47 With a current price of $3127.79 and an intrinsic value of $3817.47, AutoZone appears to be modestly undervalued with a margin of safety of 18.1%. It is important to note that GuruFocus uses EPS without non-recurring items, as research indicates that stock prices correlate more closely with earnings than with free cash flow. For further details, you can access the AZO DCF Calculator.
What Does the Free Cash Flow DCF Say? The free cash flow (FCF) based intrinsic value for AutoZone is calculated to be $2184.44 per share. When comparing this with the earnings-based intrinsic value of $3817.47, there is a significant discrepancy. The FCF model indicates that AutoZone is modestly overvalued, with a margin of safety of -43.2%.
How Does GF Value™ Compare to the DCF Models? The GF Value™ for AutoZone is calculated at $3689.05, providing a third perspective on the valuation. GF Value™ is GuruFocus' proprietary measure derived from historical trading multiples, past business growth, and future performance estimates. Comparing all three models, the earnings-based DCF suggests undervaluation, the FCF-based DCF indicates overvaluation, and GF Value™ suggests a slight undervaluation. For more insights, visit the GF Value™ page.
What Does AZO's GF Score™ Tell Us? The GF Score™ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Score™ values have historically generated higher long-term returns (backtested from 2006-2021).
Metric Rating GF Score™ 93/100 Financial Strength 5/10 Profitability 10/10 Growth 10/10 Valuation 10/10 Momentum 4/10 With a predictability rank of 2/5 stars, it is important to note that higher predictability ratings generally enhance the reliability of the DCF model for this stock. For more information, visit the AZO stock page.
Key Assumptions and Limitations It is essential to recognize that DCF models are highly sensitive to the assumptions made regarding growth rates and discount rates. Stocks with low predictability ratings tend to produce less reliable DCF estimates. The terminal growth rate of 4% is a simplifying assumption that may not reflect actual future performance.
What This Means for Investors In synthesizing the three valuation models—DCF earnings, DCF FCF, and GF Value™—the overall verdict for AutoZone Inc AZO is mixed. While the earnings-based DCF suggests the stock is modestly undervalued, the FCF model indicates it is overvalued, and GF Value™ suggests a slight undervaluation. Overall, investors should consider these varying perspectives before making investment decisions. For the full DCF analysis, visit the AZO DCF Calculator. You can also explore the GF Value™ page, or use the GuruFocus Stock Screener to find undervalued predictable companies.
Frequently Asked Questions What is AZO's intrinsic value based on DCF?
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
New corporate venture capital platform will invest to advance therapeutics, technologies and One Health solutions
, /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced plans to establish Elanco Ventures, a dedicated corporate venture capital (CVC) platform designed to support, invest and advance innovation in animal health.
To be backed by a $25 million multi-year commitment, Elanco Ventures will initially focus on strategic investments in therapeutic advancements and supportive technologies across the animal health sector.
Elanco Ventures "From pets to protein – the animal health industry has never been more relevant than it is today," said Jeff Simmons, President and CEO of Elanco. "Innovation is happening outside of the boundaries of any single company. Elanco Ventures allows us to strategically leverage the startup landscape to expand our visibility into a range of emerging technologies that help us meet pet owners' evolving expectation of care and the increasing global demand for protein."
While primarily focused on animal health, the fund may also explore opportunities within the broader One Health landscape. It will also leverage the proximity of partnerships within the One Health Innovation District in Indianapolis, anchored by Elanco and Purdue University, and designed to bring together life sciences, researchers, and entrepreneurs in one place to break innovation barriers and accelerate progress.
"Elanco Ventures embodies our commitment to partnership and innovation," said Tim Bettington, Executive Vice President, Center of Strategic Growth at Elanco. "By identifying promising startup technologies and collaborating with the One Health Innovation District, we are better positioned to fast-track innovation that can redefine the future of animal health."
Launching in late 2026, Elanco Ventures will be overseen by Eric Steager, an experienced CVC leader, and focus on early-stage companies, prioritizing Pre-Seed, Seed and Series A stages of development.
About the One Health Innovation District
The One Health Innovation District is a first-of-its-kind, purpose-built ecosystem where animal, human, and plant health intentionally converge in one connected place. Anchored by industry, research, diagnostics, care, commercialization, and talent, the district is designed to accelerate discovery to delivery and advance the future of One Health through speed, connection, and shared purpose.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. Learn more at www.elanco.com.
, /PRNewswire/ -- Investors in Primoris Services Corporation (NYSE: PRIM) saw the price of their shares crater $101.69 (-50%) on May 6, 2026 after the Company reported huge year-over-year and sequential declines in revenues and gross profits for its Energy segment and identified ongoing, expanded issues with its renewables business.
The severe market reaction and expanded renewables issues have prompted shareholder rights firm Hagens Berman to open an investigation into whether Primoris' disclosures about the health of its business before the Company reported after the market closed on May 5, 2026.
The firm encourages Primoris investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist the investigation to contact its attorneys.
Visit: https://www.hbsslaw.com/cases/primoris
Contact the Firm Now: [email protected]
844-916-0895
Hagens Berman's investigative focus is on the propriety of Primoris' statements about trends in—and operational performance of—Primoris' renewables business.
Primoris is fundamentally an energy and renewables company. In 2025, the Energy segment generated nearly two-thirds of the firm's total revenue. Within that segment, the renewable business has become the primary driver, alone accounting for roughly 40% of Primoris' entire annual revenue.
In February 2026, Primoris management attributed lower gross margins to "unexpectedly higher costs" at certain renewables projects, citing difficult soil and rock conditions that required additional labor and equipment. While management later downplayed the issue as being isolated to a single project—expressing confidence in their remedial measures—they simultaneously touted the company's ability to "accelerate project timelines" for 2026.
The market's confidence in Primoris's "remedial measures" was shattered following the release of the company's Q1 2026 financial results on May 5. The report revealed a staggering decline in the core Energy segment, with year-over-year revenues falling by $152.9 million (13.8%) and gross profits plunging by nearly 40%.
CEO Koti Vadlamudi admitted during the May 6 earnings call that Primoris's financial results were battered by cost pressures across multiple solar projects. Moving beyond the "rock and soil" reason used just months prior, Vadlamudi cited a litany of execution-related factors as the cause of the margin collapse:
Project Redesigns: Costly changes to existing plans. Labor Issues: Inability to manage specific workforce demands. Sequencing Errors: Failures in project management and timing. Weather Disruptions: Further complicating already delayed timelines The market swiftly reacted, sending the price of Primoris shares down 50% and wiping out about $5.5 billion of Primoris' market capitalization in a single day.
"We're focused on when Primoris' management learned of the renewable project execution issues revealed on the May earnings call," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.
If you invested in Primoris and have substantial losses, or have knowledge that will assist the firm's investigation, submit your losses now »
If you'd like more information and answers to other frequently asked questions about the firm's Primoris investigation, read more »
Whistleblowers: Persons with non-public information regarding Primoris should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
, /PRNewswire/ -- Investors in Primoris Services Corporation (NYSE: PRIM) saw the price of their shares crater $101.69 (-50%) on May 6, 2026 after the Company reported huge year-over-year and sequential declines in revenues and gross profits for its Energy segment and identified ongoing, expanded issues with its renewables business.
The severe market reaction and expanded renewables issues have prompted shareholder rights firm Hagens Berman to open an investigation into whether Primoris' disclosures about the health of its business before the Company reported after the market closed on May 5, 2026.
The firm encourages Primoris investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist the investigation to contact its attorneys.
Visit: https://www.hbsslaw.com/cases/primoris
Contact the Firm Now: [email protected]
844-916-0895
Hagens Berman's investigative focus is on the propriety of Primoris' statements about trends in—and operational performance of—Primoris' renewables business.
Primoris is fundamentally an energy and renewables company. In 2025, the Energy segment generated nearly two-thirds of the firm's total revenue. Within that segment, the renewable business has become the primary driver, alone accounting for roughly 40% of Primoris' entire annual revenue.
In February 2026, Primoris management attributed lower gross margins to "unexpectedly higher costs" at certain renewables projects, citing difficult soil and rock conditions that required additional labor and equipment. While management later downplayed the issue as being isolated to a single project—expressing confidence in their remedial measures—they simultaneously touted the company's ability to "accelerate project timelines" for 2026.
The market's confidence in Primoris's "remedial measures" was shattered following the release of the company's Q1 2026 financial results on May 5. The report revealed a staggering decline in the core Energy segment, with year-over-year revenues falling by $152.9 million (13.8%) and gross profits plunging by nearly 40%.
CEO Koti Vadlamudi admitted during the May 6 earnings call that Primoris's financial results were battered by cost pressures across multiple solar projects. Moving beyond the "rock and soil" reason used just months prior, Vadlamudi cited a litany of execution-related factors as the cause of the margin collapse:
Project Redesigns: Costly changes to existing plans.Labor Issues: Inability to manage specific workforce demands.Sequencing Errors: Failures in project management and timing.Weather Disruptions: Further complicating already delayed timelinesThe market swiftly reacted, sending the price of Primoris shares down 50% and wiping out about $5.5 billion of Primoris' market capitalization in a single day.
"We're focused on when Primoris' management learned of the renewable project execution issues revealed on the May earnings call," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.
If you invested in Primoris and have substantial losses, or have knowledge that will assist the firm's investigation, submit your losses now »
If you'd like more information and answers to other frequently asked questions about the firm's Primoris investigation, read more »
Whistleblowers: Persons with non-public information regarding Primoris should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
View original content to download multimedia:https://www.prnewswire.com/news-releases/primoris-services-prim-shares-crater-50-amid-expanded-renewables-issues--hbss-302804987.html
Boston, Massachusetts--(Newsfile Corp. - June 19, 2026) - Block & Leviton is investigating Primoris Services Corporation (NYSE: PRIM) for potential securities law violations. Investors who have lost money in their Primoris Services Corporation investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/prim.
What is this all about?
Primoris Services Corporation's stock fell over 45% on May 6, 2026, after the company reported Q1 2026 results below analyst expectations and slashed full-year adjusted EBITDA guidance from $560-$580 million to $480-$500 million. In its May 5, 2026 earnings release, Primoris attributed the reduction to lower renewable energy activity, delayed project starts, and increased costs on renewable energy projects. This contrasts with statements made on the company's February 24, 2026 Q4 2025 earnings call, when Primoris told investors, "We've accounted for all of these increased costs and expect renewables margins to improve as we progress into 2026."
Who is eligible?
Anyone who purchased Primoris Services Corporation common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.
What is Block & Leviton doing?
Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.
What should you do next?
If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at [email protected], or by phone at (888) 256-2510.
Whistleblower?
If you have non-public information about Primoris Services Corporation, you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at [email protected] or by phone at (888) 256-2510.
Why should you contact Block & Leviton?
Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website www.blockleviton.com, call (888) 256-2510 or email [email protected] with any questions.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302198
Source: Block & Leviton LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
The energy landscape in 2026 presents a choice between massive global scale and targeted regional growth. Choosing between ConocoPhillips (COP 2.99%) and Viper Energy (VNOM 0.35%) depends on your preference for diversification or specialization.
ConocoPhillips is one of the world’s largest independent explorers, while Viper Energy focuses on mineral and royalty interests. Both companies benefit from robust production in the Permian Basin, but they navigate the market with very different business structures and capital requirements.
The case for ConocoPhillipsConocoPhillips sells oil and natural gas to global markets, utilizing diverse partnerships and long-term contracts. Key strategic partners include QatarEnergy and Shell plc (SHEL 1.95%), with significant activity in Norway, Canada, and the United States. As global markets transition, many investors are also watching renewable energy stocks to balance their exposure to fossil fuels.
In FY 2025, revenue reached $61.6 billion, representing growth of 8.0% over the previous year. The company reported net income of approximately $8.0 billion, which resulted in a net margin of nearly 13%. This net margin, which measures how much profit is kept from every dollar of sales, declined from the 16.2% reported in FY 2024.
As of its December 2025 balance sheet, the debt-to-equity ratio was approximately 0.4x. This ratio compares total debt to shareholders’ equity, indicating that the company uses a moderate level of borrowing to fund its operations. Free cash flow was close to $7.2 billion, which is the cash a company generates after paying for its capital investments.
The case for Viper EnergyViper Energy owns mineral and royalty interests, meaning it collects payments from oil production without bearing the costs of drilling wells. Its primary operator is Diamondback Energy (FANG 1.45%), which manages roughly 35% of the company's net royalty acreage. The company recently tightened its focus by divesting non-Permian assets to GRP Energy Capital and Warwick Capital Partners.
During FY 2025, revenue reached nearly $1.4 billion, an increase of roughly 62% on the year. The net loss for 2025 was $68.0 million. This loss reflects a significant shift from the net income of roughly $359.2 million earned during the previous fiscal year. Free cash flow for the period was close to negative $1.3 billion.
Risk profile comparisonConocoPhillips faces significant risks from commodity price volatility, as its revenues are highly sensitive to crude oil and natural gas prices. The company also navigates heavy regulatory pressure regarding climate change and ongoing litigation that could impose substantial legal costs. Additionally, the business must constantly replace its produced reserves through complex permitting and capital-intensive projects to ensure long-term production.
Viper Energy is heavily dependent on Diamondback Energy, as any operational delays by this primary operator directly reduce royalty revenues. Unlike some peers, the company has high exposure to price swings because it does not hedge its production heavily. Furthermore, recent aggressive acquisitions require successful integration to realize expected cash flows, while new environmental regulations in the Permian Basin could force operators to curtail production.
Valuation comparisonConocoPhillips appears to be the value play with a lower Forward P/E, while Viper Energy trades at a higher P/S ratio reflecting its growth.
MetricConocoPhillipsViper EnergySector BenchmarkForward P/E10.6x21.2x20.8xP/S ratio2.2x4.1xSector benchmark uses the SPDR XLE sector ETF.
Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
Companies that rely on oil and gas production are bound to be exposed to the volatility of global commodity prices. Oil in particular has been subject to wide swings this year, thanks to the Iran war. Natural gas, meanwhile, is trading around its long-term average in the U.S. and has been more stable than crude oil.
Still, in an environment where oil prices could be quite volatile for a long period of time, ConocoPhillips has the edge. ConocoPhillips is one of the world’s largest independent exploration and production (E&P) businesses in terms of production and proved reserves. It’s a much more diversified business than Viper Energy, in terms of its global scale and the diversity of businesses in its portfolio. For ConocoPhillips, that includes natural gas marketing, licensing of its LNG technologies, and operating a fleet of tankers to safely transport oil.
ConocoPhillips’ scale has enabled it to increase revenue in 2025 over 2024. In particular, the company decided to remain unhedged this year to capture upside in oil prices, which should help it meet a $71 billion consensus revenue target. A key point for investors to note, too: COP is one of the best dividend-paying stocks in the S&P 500, paying out $3.30 per share over the past year.
Theoretically, Viper Energy should be an even better investment because it is a capital-light business — it doesn’t need to invest in oil rigs or pipelines because the companies they lease to handle that: Viper just collects money. But as 2025’s $60 milllion net loss shows, there are still downsides to the business. The primary one is that mineral rights are depleting — eventually, oil and gas fields get tapped out or become uneconomic to extract. That means Viper needs to constantly buy new acreage to replenish its reserves, leaving it susceptible to oil and gas prices that could affect its ability to attract companies to lease its fields. Viper is expected to make a big comeback in profitability this year, with analysts projecting more than $ 500 million in net income on $2.3 billion in revenue. It doesn’t pay a dividend, however.
But in an uncertain market, the size and scale of ConocoPhillips and its relative value compared to Viper, plus its healthy commitment to paying dividends, give it the nod for 2026.
The Retail-Wholesale group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Casey's General Stores (CASY - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Casey's General Stores is one of 189 individual stocks in the Retail-Wholesale sector. Collectively, these companies sit at #13 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Casey's General Stores is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for CASY's full-year earnings has moved 5.5% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
According to our latest data, CASY has moved about 56.6% on a year-to-date basis. In comparison, Retail-Wholesale companies have returned an average of 1.9%. This shows that Casey's General Stores is outperforming its peers so far this year.
One other Retail-Wholesale stock that has outperformed the sector so far this year is Murphy USA (MUSA - Free Report) . The stock is up 41.3% year-to-date.
For Murphy USA, the consensus EPS estimate for the current year has increased 29.9% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Casey's General Stores belongs to the Retail - Convenience Stores industry, a group that includes 2 individual companies and currently sits at #3 in the Zacks Industry Rank. On average, this group has gained an average of 52.5% so far this year, meaning that CASY is performing better in terms of year-to-date returns. Murphy USA is also part of the same industry.
Investors with an interest in Retail-Wholesale stocks should continue to track Casey's General Stores and Murphy USA. These stocks will be looking to continue their solid performance.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
#1 (Strong Buy) stocks have produced an unmatched +24% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.
For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Casey's General Stores (CASY - Free Report) Founded in 1959 and based in Ankeny, IA, Casey's General Stores, Inc. operates convenience stores under the Casey's and Casey's General Store names in 19 states, mainly Iowa, Missouri and Illinois.As of Jan. 31, 2026 the company operated approximately 2,924 stores.
CASY is a #1 (Strong Buy) on the Zacks Rank, with a VGM Score of B.
Additionally, the company could be a top pick for growth investors. CASY has a Growth Style Score of A, forecasting year-over-year earnings growth of 9.1% for the current fiscal year.
Five analysts revised their earnings estimate upwards in the last 60 days for fiscal 2027. The Zacks Consensus Estimate has increased $0.83 to $20.90 per share. CASY boasts an average earnings surprise of +18.4%.
With a solid Zacks Rank and top-tier Growth and VGM Style Scores, CASY should be on investors' short list.
In this article series, I summarize dividend announcements of the past week. Seven stocks in my database announced dividend increases, with CASY leading at 14.04% and O posting a token. CASY and CAT are high-quality, premium compounders but trade 24% and 21% above fair value, respectively, limiting near-term value. NFG stands out for value, trading 5% below fair value with a balanced 2.86% yield and consistent dividend growth.
Key Takeaways Retail sales rose 0.9% in May, marking a fourth straight monthly increase and 6.9% annual growth.Online retail sales gained 1.5% in May, while auto dealership receipts increased 1.2%.CASY, FIVE, SBUX, TPR and TJX saw positive earnings estimate revisions in the past 60 days. Americans are spending aggressively amid inflationary pressures. A surge in oil prices since the beginning of the Iran war in late February has been pushing up the prices of goods. However, the retail sector has shown immense resilience amid these challenges.
Retail sales have been on the rise at a steady pace this year, driven by high demand for consumer goods. Given this situation, it would be ideal to invest in retail stocks with a strong online presence. We have selected five stocks, namely, Casey's General Stores, Inc. (CASY - Free Report) , Five Below, Inc. (FIVE - Free Report) , Starbucks Corporation (SBUX - Free Report) , Tapestry (TPR - Free Report) and The TJX Companies, Inc. (TJX - Free Report) .
These stocks have seen positive earnings estimate revisions in the past 60 days, carry a Zacks Rank #1 (Strong Buy) or 2 (Buy) and are set for solid returns. You can see the complete list of today’s Zacks #1 Rank stocks here.
Retail Sales Continue to GrowRetail sales rose 0.9% sequentially in May after increasing 0.4% in the prior month and surpassing analysts’ expectations of a rise of 0.5%. This is the fourth straight month that retail sales have surged. Year over year, retail sales jumped 6.9% in May.
The surge in retail sales was primarily driven by aggressive spending by households on motor vehicles.
Receipts at auto dealerships rose 1.2%, while sales at non-store retailers, which include online retailers, gained 1.5% in May. Sales at furniture stores jumped 1%.
Although part of the rise can be attributed to high oil prices, which saw consumers paying more for gasoline, many believed that the surge was temporary. Oil prices have jumped to a four-year high since the Middle East crisis began in late February.
However, energy costs have eased lately, which is being seen as a positive. Consumer sentiment also rose for the first time in three months in June. The University of Michigan’s latest survey showed that consumer sentiment rose 9% to a preliminary reading of 48.9 in June.
Oil prices are likely to ease further as the United States announced that it has reached a peace deal with Iran, which is likely to be signed soon. The peace deal would allow the reopening of the Strait of Hormuz, a key route for the smooth passage of oil tankers and ships.
Meanwhile, the Federal Reserve left interest rates unchanged in its current range of 3.5-3.75% at the end of its policy meeting on Wednesday. The Fed is mulling an interest rate hike sometime later this year, which could weigh on the retail sector. However, solid demand and aggressive spending have been boosting the retail sector.
5 Retail Stocks With UpsideCasey's General StoresCasey's General Stores, Inc. operates convenience stores under the Casey's and Casey's General Store names in 16 states, mainly Iowa, Missouri and Illinois. CASY offers a comprehensive range of products and services to meet the needs of its customers. In addition to fuel, the stores provide a wide variety of merchandise, including groceries, prepared food, snacks, beverages, tobacco products, health and beauty aids, school supplies, housewares, pet supplies and automotive supplies.
Casey’s has an expected earnings growth rate of 9.1% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 4.1% over the last 60 days. CASY currently has a Zacks Rank #2.
Five Below, IncFive Below, Inc. is a specialty value chain retailer that provides a wide range of premium quality and trendy merchandise for $5 or below. FIVE mainly targets teenagers or pre-teen shoppers for its products, which include certain brands and licensed merchandise. Notably, these products belong to categories such as Style, Room, Sports, Tech, Create, Party, Candy and Now.
Five Below’s expected earnings growth rate for the current year is 30.4%. The Zacks Consensus Estimate for current-year earnings has improved 8.1% over the past 60 days. FIVE presently carries a Zacks Rank #1.
Starbucks CorporationStarbucks Corporation is the leading roaster and retailer of specialty coffee globally. In addition to fresh, rich-brewed coffees, SBUX’s offerings include many complimentary food items and a selection of premium teas and other beverages, sold mainly through the company’s retail stores. Starbucks’popular brands include Starbucks coffee, Teavana tea, Seattle's Best Coffee, La Boulange bakery products and Evolution Fresh juices.
Starbucks’ expected earnings growth rate for next year is 12.7%. The Zacks Consensus Estimate for current-year earnings has improved 4.3% over the past 60 days. SBUX currently has a Zacks Rank #1.
TapestryTapestry is the designer and marketer of fine accessories and gifts for women and men in the United States and internationally. TPR offers lifestyle products, which include handbags, women’s and men’s accessories, footwear, jewelry, seasonal apparel collections, sunwear, travel bags, fragrances and watches.
Tapestry’sexpected earnings growth rate for the current year is 36.3%. The Zacks Consensus Estimate for current-year earnings has improved 7.8% over the past 60 days. TPR presently sports a Zacks Rank #1.
The TJX CompaniesThe TJX Companies, Inc. is a leading off-price retailer of apparel and home fashions in the United States and worldwide. TJX’s broad range of assortments at varying prices helps it reach out to a broad range of consumers. In addition, The TJX Companies tries to attract consumers through a rapid turnover of inventory.
The TJX Companies’ expected earnings growth rate for the current year is 9.3%. The Zacks Consensus Estimate for current-year earnings has improved 2.2% over the past 60 days. TJX presently has a Zacks Rank #2.
For investors looking to benefit from the long-term value of the Knicks franchise, MSGS is the more direct investment opportunity, while MSGE may appeal to those who prefer a broader entertainment and venue-based business model.
New York, NY, June 17, 2026 (GLOBE NEWSWIRE) -- CCS Fundraising, in partnership with the Indiana University Lilly Family School of Philanthropy, will host its annual “Perspectives on Philanthropy” webinar on Tuesday, June 23, 2026, from 1:00 to 2:15 PM ET, examining the latest findings from Giving USA 2026: The Annual Report on Philanthropy in 2025.
This 75-minute session will share insights from the most comprehensive dataset on U.S. charitable giving, exploring where growth is occurring, how philanthropic patterns are evolving, and what these trends mean for nonprofit leaders navigating today’s environment. Giving USA is a publication of the Giving USA Foundation, researched and written by the Indiana University Lilly Family School of Philanthropy.
The webinar will feature Jon Bergdoll, Interim Director of Data and Research Partnerships at the Indiana University Lilly Family School of Philanthropy and long-time lead analyst for the Giving USA report. Bergdoll will present key findings and takeaways from this year’s research.
The session will be hosted by Peter Hoskow, President and Chief Operating Officer of CCS Fundraising, and will include perspectives from sector leaders representing national nonprofit organizations across education, healthcare, and foundation sectors, including:
• Dexter A. Bailey, Jr., Vice President for Advancement and Alumni Relations, California Institute of Technology (Caltech)
• Brent Christopher, President, Children’s Medical Center Foundation
• Rebecca Fishman Lipsey, President and CEO, The Miami Foundation
Together, the panel will discuss how organizations can translate Giving USA insights into actionable strategies for fundraising, donor engagement, and long-term growth.
Event Details
What: Perspectives on Philanthropy: Giving USA 2026 Webinar
When: Tuesday, June 23, 2026 | 1:00 – 2:15 PM ET
Where: Virtual
Registration: Register here.
Attendees will gain a clear, data-driven view of the current philanthropic landscape, along with practical perspectives to inform planning and decision-making in the year ahead.
To register or learn more, visit the event registration page.
###
About CCS Fundraising
CCS Fundraising is a strategic consulting firm that has partnered with nonprofit organizations to create meaningful impact for 79 years. CCS provides a wide range of services to strengthen and advance fundraising programs, including campaign management, strategic planning and studies, data analytics, gift planning, systems and change management, and major gift strategy. Named one of Forbes’ America’s Best Management Consulting Firms 2026 based on recommendations from clients and consulting peers, CCS executives partner closely with organizations of all sizes across every nonprofit sector, offering both national and international perspective along with deep local expertise.
About Indiana University Lilly Family School of Philanthropy
The Indiana University Lilly Family School of Philanthropy is dedicated to improving philanthropy and the world by training and empowering students and professionals to be innovators and leaders who create positive and lasting change. The school offers a comprehensive approach to philanthropy through its undergraduate, graduate, Ph.D., PhilD, certificate and professional development programs, its research and international programs and through The Fund Raising School, Lake Institute on Faith & Giving, the Mays Family Institute on Diverse Philanthropy and the Women’s Philanthropy Institute. Follow us on X (formerly Twitter), LinkedIn, and Facebook.
About Giving USA Foundation
For 70 years, Giving USA: The Annual Report on Philanthropy in America, has provided comprehensive charitable giving data that are relied on by donors, fundraisers and nonprofit leaders. The research in this annual report estimates all giving to charitable organizations across the United States. Giving USA is a public outreach initiative of Giving USA Foundation and is researched and written by the Indiana University Lilly Family School of Philanthropy at IU Indianapolis. Giving USA Foundation, established in 1985 by The Giving Institute, endeavors to advance philanthropy through research and education. Explore Giving USA products and resources, at www.givingusa.org.
About The Giving Institute
The Giving Institute, the parent organization of Giving USA Foundation, consists of member organizations that have embraced and embodied the core values of ethics, excellence and leadership in advancing philanthropy. Serving clients of every size and purpose, from local institutions to international organizations, The Giving Institute member organizations embrace the highest ethical standards and maintain a strict code of fair practices. For information on selecting fundraising counsel, visit www.givinginstitute.org.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: AMN Healthcare Services (AMN - Free Report) AMN Healthcare Services, Inc. (AMN - Free Report) , operating from Dallas, TX, is a travel healthcare staffing company. Its business has evolved beyond traditional healthcare staffing and recruitment services, thereby becoming a strategic total talent solutions partner with its clients. It has expanded its portfolio to serve a diverse and growing set of healthcare talent-related needs. In addition to its healthcare professional staffing and recruitment services, AMN’s suite of healthcare workforce solutions includes MSP, vendor management systems (VMS), medical language interpretation services, predictive labor analytics, workforce optimization technology and consulting, recruitment process outsourcing (RPO), revenue cycle solutions, credentialing services and virtual care management services. AMN enables its clients to build, manage and optimize their healthcare talent to deliver improved patient outcomes and experience. It continues to enhance its platform with technology-enabled solutions, including digital workforce platforms, automation tools and AI-driven capabilities to improve speed, efficiency and clinician engagement.
AMN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 11.81; value investors should take notice.
Three analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.77 to $2.70 per share. AMN boasts an average earnings surprise of +53.3%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, AMN should be on investors' short list.
SG Americas Securities LLC boosted its stake in shares of ONE Gas, Inc. (NYSE: OGS) by 3,436.1% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 136,811 shares of the utilities provider's stock after acquiring an additional 132,942 shares during the period. SG Americas Securities LLC
Reaffirms 2026 Guidance June 17, 2026 16:30 ET | Source: Certara
RADNOR, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announces that John Gallagher, Chief Financial Officer, has notified the Company of his intent to resign from his office effective as of the end of the day on July 14, 2026.
Concurrently, Certara has launched a search with a leading executive search firm to identify the Company's next Chief Financial Officer.
Faiz Mohammed, Certara's Senior Vice President of Finance and Treasurer, has agreed to serve as Interim CFO upon Mr. Gallagher's departure until a successor is named and appointed. Mr. Mohammed has been a finance leader with Certara since 2018 and brings more than 25 years of senior finance and accounting experience across public and private equity-backed companies.
Certara Reaffirms 2026 Guidance
Certara takes this opportunity to reaffirm the Company’s 2026 Financial Guidance provided during the first quarter earnings call on May 11, 2026.
About Certara
Certara transforms drug discovery and development for good, helping scientists and clinical teams generate regulatory-grade evidence faster. Its solutions combine biosimulation, clinical intelligence, and regulatory science, and are embedded in the workflows of drug developers worldwide. Certara clients include more than 2,600 biopharmaceutical companies, academic institutions, and global regulatory agencies. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group [email protected]
Forward Looking Statements
This press release contains certain statements that constitute forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the Company’s financial guidance, management succession plans and future business and financial performance and outlook. Actual results may differ materially from those described in the forward-looking statements and are subject to a variety of assumptions, uncertainties, risks and factors that are beyond our control, including disruption from the recently completed divestiture of our Regulatory Medical Writing business transaction making it more difficult to maintain business and operational relationships; any deceleration in, or resistance to, the acceptance of model-informed biopharmaceutical discovery and development; our ability to compete within our market; changes or delays in government regulation relating to the biopharmaceutical industry; trends in research and development spending; operational disruptions, funding constraints and policy changes at the Food and Drug Administration and other government agencies; consolidation within the biopharmaceutical industry; our ability to increase successfully our customer base, expand relationships and the products and services we provide and enter new markets; our ability to retain key personnel or recruit additional qualified personnel; risks related to the mischaracterization of our independent contractors; any delays or defects in our release of new or enhanced software or other biosimulation tools; issues relating to implementation, use and development of artificial intelligence and machine learning in our products and services; failure of our existing customers to renew their software licenses or any delays or terminations of contracts or reductions in scope of work by our existing customers; risks related to our contracts with government customers and receipt of government grants; risks related to any future acquisitions and other strategic transactions; the accuracy of our addressable market estimates; our ability to operate successfully a global business and adverse global economic conditions; our ability to comply with applicable trade compliance and economic sanctions laws and regulations; the impact of litigation; the sufficiency of our insurance coverage; our ability to perform our services in accordance with contractual requirements, regulatory standards and ethical considerations; the loss of more than one of our major customers; our ability to raise capital or generate sufficient cash flows; the ability or inability of our bookings to accurately predict our future revenue and our ability to realize the anticipated revenue reflected in our; our ability to comply with anti-corruption laws; risks related to catastrophic events; the application of evolving corporate governance and public disclosure requirements; disruptions in the operations of the third-party providers who host our software solutions or any limitations on their capacity or interference with our use; any unauthorized access to or use of customer or other proprietary or confidential data or other breach of our cybersecurity measures, compliance with privacy and cybersecurity laws and related contractual requirements; our ability to reliably meet our data storage and management requirements, or the experience of any failures or interruptions in the delivery of our services over the internet; our ability to comply with the terms of any licenses governing our use of third-party open source software; our ability to adequately enforce or defend our ownership and use of our intellectual property and other proprietary rights; any allegations that we are infringing, misappropriating or otherwise violating a third party’s intellectual property rights; our ability to comply with healthcare laws; risks related to our indebtedness; any additional impairment of goodwill or other intangible assets; our ability to use net operating losses; the volatility of the market price of our common stock; future sales of our common stock by existing stockholders; the substantial holdings of our largest stockholder; and the other factors detailed under the captions “Risk Factors” and “Special Note Regarding Forward-Looking Statements” and elsewhere in our Securities and Exchange Commission (“SEC”) filings, and reports, including the Form 10-K filed by the Company with the Securities and Exchange Commission on February 26, 2026, and subsequent reports filed with the SEC. Any forward-looking statements speak only as of the date of this release and, except to the extent required by applicable securities laws, we expressly disclaim any obligation to update or revise any of them to reflect actual results, any changes in expectations or any change in events.
SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Certara, Inc. (NASDAQ: CERT). The investigation focuses on Certara’s executive officers and whether investor losses may be recovered under federal securities laws.
What if I purchased Certara securities?
If you purchased Certara securities and suffered losses on your investment, join our investigation now: Click here to join the investigation.
Or for more information, contact Jim Baker at [email protected] or (619) 814-4471.
There is no cost or obligation to you.
Background of the investigation
On May 11, 2026, Certara reported its first quarter 2026 financial results. Certara disclosed that services revenue declined 4% year-over-year to $57.2 million, while services bookings declined 14% year-over-year to $66.6 million. In discussing the quarter, Certara stated that it saw “softer performance from Tier 1 customers in MIDD services” and that services performance was “mixed.” The Company also discussed execution and go-to-market challenges in its services business and stated, in response to a question about consistency between software and services performance, that there had been “a lot of inconsistency and back and forth” over the last few quarters.
Following this news, Certara’s stock price declined sharply, damaging investors.
Then, on June 17, 2026, Certara announced a Chief Financial Officer transition, disclosing that John Gallagher, the Company’s Chief Financial Officer, had notified Certara of his intent to resign effective as of the end of the day on July 14, 2026. Certara also announced that Faiz Mohammed, the Company’s Senior Vice President of Finance and Treasurer, would serve as Interim Chief Financial Officer following Mr. Gallagher’s departure while the Company searches for a permanent successor.
In light of this disclosure, Johnson Fistel is investigating whether Certara complied with the federal securities laws. If you suffered losses from your investment in Certara stock, contact Johnson Fistel.
About Johnson Fistel, PLLP | Securities Fraud & Investor Rights
Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits and also assists foreign investors who purchased shares on U.S. exchanges. To learn more, visit www.johnsonfistel.com.
Achievements
In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services, reflecting the firm’s effectiveness in advocating for investors and recovering approximately $90,725,000 for clients in cases where it served as lead or co-lead counsel.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact
Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker, Investor Relations – or – Frank J. Johnson, Esq.
(619) 814-4471 | [email protected]
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Certara (CERT) To Contact Him Directly To Discuss Their Options
If you purchased or acquired stock in Certara and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.
Click here to participate in the action.
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) --
What’s Happening:
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Certara, Inc. (“Certara” or the “Company”) (NASDAQ: CERT) on behalf of Certara stockholders. Our investigation concerns whether Certara has violated the federal securities laws and/or engaged in other unlawful business practices.
Investigation Details:
On May 11, 2026, Certara announced its financial results for the first quarter of 2026. Among other disclosures, the Company reported that services revenue declined 4% year over year to $57.2 million, while services bookings decreased 14% year over year to $66.6 million. In discussing the quarter, Certara stated that it experienced “softer performance from Tier 1 customers in MIDD services” and described services performance as “mixed.” The Company also announced its exit from the regulatory business within its services segment. In response to a question regarding consistency between software and services performance, the Company stated that there had been “a lot of inconsistency and back and forth” over the last several quarters. Following this news, the price of Certara shares fell by $1.18 per share, or approximately 19%, declining from $6.31 per share on May 8, 2026 to close at $5.13 per share on May 11, 2026.
Next Steps:
If you purchased or otherwise acquired Certara shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
Key Takeaways RBC's Aerospace & Defense revenues jumped 41.2% year over year in fiscal Q4 2026.RBC benefits from a $2.3 billion backlog and strong execution on commercial aerospace orders.RBC saw defense revenues rise 64.5%, supported by marine and missile program demand. RBC Bearings Incorporated (RBC - Free Report) is benefiting from the strong performance of the Aerospace & Defense segment. Strength in the commercial aerospace market, driven by strong growth in orders from the OEM (original equipment manufacturer) and the aftermarket verticals, is driving the segment’s results. In the fourth quarter of fiscal 2026 (ended March 28, 2026), revenues from the segment surged 41.2% year over year.
The robust backlog level of $2.3 billion, exiting the quarter, along with the company’s strong execution on incremental orders in the commercial aerospace market, is expected to be a tailwind for the segment.
While the commercial aerospace market has remained a key driver for RBC, the defense side of the industry is also showing positive momentum. Solid demand for the company’s bearings and engineered component products in the defense market, supported by marine and missile programs, bodes well for the segment moving ahead. Within the segment, revenues from the commercial aerospace market increased 17.8% in the fiscal fourth quarter, while those from the defense market surged 64.5%.
RBC’s Aerospace & Defense unit is expected to maintain a strong growth trajectory going forward, supported by robust budgetary provisions for the U.S. defense sector and strength in air travel.
RBC’s Peers in the Aerospace & Defense MarketCommercial aircraft and aftermarket activity continue to support Textron Inc.’s (TXT - Free Report) Aviation franchise. In the first quarter of 2026, Textron Aviation revenues increased 22% year over year, driven by higher aircraft revenues and a 10% increase in aftermarket parts and services revenues. Backlog at Textron Aviation rose to $8.0 billion as of April 4, 2026, from $7.7 billion at year-end 2025.
RTX Corporation (RTX - Free Report) is witnessing solid momentum in commercial aerospace, strong defense orders and a robust backlog. Rising global air traffic, higher commercial OEM and aftermarket sales, and strong demand for large commercial engines and Pratt Canada operations should aid RTX’s growth. RTX Corp.’s defense business remains well-positioned, backed by strong bookings from the Pentagon and foreign allies.
RBC's Price Performance, Valuation and EstimatesShares of RBC Bearings have surged 38.7% in the past six months compared with the industry’s growth of 6.5%.
Image Source: Zacks Investment Research
From a valuation standpoint, RBC is trading at a forward price-to-earnings ratio of 42.54X, above the industry’s average of 22.60X. RBC Bearings carries a Value Score of F.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for RBC’s fiscal 2027 (ending March 2027) earnings has been on the rise over the past 60 days.
Image Source: Zacks Investment Research
RBC Bearings currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD LiveCustomer Center
My Stock Lists
Email Preferences
Help & Support
Sign Out
Search stocks or keywords
Sections
My IBD
MARKET TREND
STOCK LISTS
STOCK RESEARCH
NEWSECONOMY
VIDEOS & PODCASTS
HOW TO INVESTEDUCATIONAL RESOURCESStoreMy Products
Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD Live
Recently Searched
Stock Market Week Ahead: Rebalancing And Technical Support
The Best Investments Beyond AI
Teradyne Hits Record High, Joins 2 Best Stock Lists And Leads 17 Others To IBD 50, Big Cap 20, More A common investing theme reappears in this week's stocks to watch: AI data centers. Quanta Services (PWR), Vertiv Holdings (VRT), Teradyne (TER) and GE Vernova (GEV) are all benefiting from massive spending on data centers, which handle the artificial intelligence traffic. RBC Bearings (RBC), another stock to watch, is primarily a defense and aerospace play. There's been pushback on data…
, /PRNewswire/ -- Cousins Properties (NYSE: CUZ) announced today that its Board of Directors has declared a cash dividend of $0.32 per common share for the second quarter of 2026. The second quarter dividend will be payable on July 16, 2026 to common shareholders of record on July 6, 2026.
About Cousins Properties
Cousins Properties is a fully integrated, self-administered and self-managed real estate investment trust (REIT). The Company, based in Atlanta, GA and acting through its operating partnership, Cousins Properties LP, primarily invests in Class A office buildings located in high growth Sun Belt markets. Founded in 1958, Cousins creates shareholder value through its extensive expertise in the development, acquisition, leasing, and management of high-quality real estate assets. The Company has a comprehensive strategy in place based on a simple platform, trophy assets, and opportunistic investments. For more information, please visit www.cousins.com.
This press release does not constitute an offer of any securities for sale. Certain matters discussed in this press release are forward-looking statements within the meaning of the federal securities laws and are subject to uncertainties and risk and actual results may differ materially from projections. Readers should carefully review Cousins' financial statements and notes thereto, as well as the risk factors described in Part I, Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and other documents Cousins files from time to time with the Securities and Exchange Commission. Such forward-looking statements are based on current expectations and speak as of the date of such statements. Cousins undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of future events, new information or otherwise.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Acuity Inc. (NYSE:AYI) will release its third quarter earnings report before the opening bell on Thursday, June 25.
Analysts expect the Atlanta, Georgia-based company to report quarterly earnings of $5.16 per share, up from $5.12 per share in the year-ago period. The consensus estimate for Acuity's quarterly revenue is $1.18 billion. It reported $1.18 billion last year, according to Benzinga Pro.
On April 2, Acuity reported mixed fiscal second-quarter 2026 results.
Acuity shares fell 0.2% to close at $305.66 on Wednesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
Considering buying AYI stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
The upcoming report from Acuity (AYI - Free Report) is expected to reveal quarterly earnings of $5.16 per share, indicating an increase of 0.8% compared to the year-ago period. Analysts forecast revenues of $1.18 billion, representing an increase of 0.4% year over year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Acuity metrics that are commonly monitored and projected by Wall Street analysts.
The combined assessment of analysts suggests that 'Net Sales by Channel- Acuity Intelligent Spaces' will likely reach $289.17 million. The estimate indicates a year-over-year change of +9.5%.
The consensus estimate for 'Net Sales by Channel- Acuity Brands Lighting (ABL)- Total' stands at $903.59 million. The estimate indicates a change of -2.1% from the prior-year quarter.
Analysts forecast 'Adjusted operating profit- Acuity Intelligent Spaces' to reach $68.32 million. Compared to the current estimate, the company reported $62.30 million in the same quarter of the previous year.
Analysts predict that the 'Adjusted operating profit- Acuity Brands Lighting' will reach $177.01 million. The estimate compares to the year-ago value of $173.90 million.
View all Key Company Metrics for Acuity here>>>
Over the past month, Acuity shares have recorded returns of +13% versus the Zacks S&P 500 composite's +1.4% change. Based on its Zacks Rank #3 (Hold), AYI will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Dominic Dragisich, Interim CEO of Choice Hotels (CHH +1.06%), reported the exercise of 12,796 stock options followed by the sale of 22,621 common shares in an open-market transaction on May 26, 2026, as disclosed in an SEC Form 4 filing.
Transaction summaryMetricValueShares sold (direct)22,621Transaction value~$2.58 millionPost-transaction shares (direct)81,607Post-transaction value (direct ownership)~$9.28 millionTransaction value based on SEC Form 4 weighted average reported price ($114.25); post-transaction value based on May 26, 2026 closing market price ($113.71).
Key questionsHow does the transaction size compare to Dragisich's previous insider sales?
The 22,621 shares sold in this event exceed all prior sell transactions by Dragisich since July 2023 except for the July 11, 2023 sale of 15,877 shares and the Oct. 11, 2024 sale of 9,138 shares; subsequent events ranged from 800 to 5,000 shares, underscoring the larger scale of this disposition as available holdings have decreased.What proportion of Dragisich's current position remains after the transaction?
Direct holdings declined from 104,000 to 81,607 shares, with the post-transaction position representing 0.18% of outstanding shares as of the latest report.What is the derivative context behind the reported trade?
This filing reflects the exercise of 12,796 options followed by immediate sale of 22,621 shares.Company overviewMetricValueRevenue (TTM)$1.60 billionNet income (TTM)$344.08 millionDividend yield1.00%1-year price change-12.10%* 1-year performance calculated using May 26, 2026 as the reference date.
Company snapshotChoice Hotels franchises a portfolio of hotel brands including Comfort Inn, Quality, Clarion, Sleep Inn, Econo Lodge, Radisson, and upscale Cambria Hotels; also offers cloud-based property management software.It generates revenue primarily through franchise fees, royalty payments, and technology services to hotel owners and operators.The company serves independent hotel owners, operators, and travelers in the midscale, economy, and upscale lodging segments across 35 countries.Choice Hotels is a leading global hotel franchisor with over 7,500 hotels and 650,000 rooms under management as of March 31, 2026. The company leverages a scalable franchise model and proprietary technology platforms to drive growth and operational efficiency.
Its diversified brand portfolio and focus on both midscale and upscale segments of the travel industry provide a competitive edge in the global lodging market.
What this transaction means for investorsThe May 26 sale of Choice Hotels stock by Dominic Dragisich came at an interesting time. He was the company’s Chief Growth and Strategy Officer until longtime CEO Patrick Pacious suddenly stepped down on May 20. That’s when Dragisich was tapped by the Board of Directors to take over as Interim CEO.
As a result, Dragisich’s disposition occurred just days after taking the top job. Despite this, his sale is not a red flag for investors. It was a non-discretionary transaction, executed as part of a pre-arranged Rule 10b5-1 trading plan adopted in February of 2026.
Such plans are often implemented by insiders to avoid accusations of trading based on insider information. Therefore, Dragisich’s sale was planned before he took over the CEO role.
The change in leadership adds to a bumpy year for Choice Hotels. Although revenue reached a company record $340.6 million in the first quarter, rising costs contributed to a drop in net income to $20.3 million compared to $44.5 million in Q1 of last year.
Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Simpson Manufacturing (SSD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Certified for the fifth consecutive year in the United States, and recognised across Bulgaria, Honduras, India, Mexico, the Philippines, South Africa, and the United Kingdom
LONDON--(BUSINESS WIRE)--ResultsCX, a provider of Customer Experience Management (CXM) services to leading global companies, including Fortune 100 and FTSE 250 brands, today announced it has earned Great Place To Work® Certification™ in eight countries: Bulgaria, Honduras, India, Mexico, the Philippines, South Africa, the United Kingdom, and the United States. The recognition reflects the strength of a globally aligned, locally relevant culture that supports performance at scale.
Great Place To Work®, the global authority on workplace culture, awards its Certification™ based entirely on direct, confidential employee feedback. Across all certified markets, employees reported a consistently positive experience, highlighting ResultsCX’s ability to foster a unified culture across diverse geographies.
This year’s recognition marks the fifth consecutive Great Place To Work® Certification™ for ResultsCX in the United States. Operations in Bulgaria, Honduras, India, Mexico, the Philippines, and the United Kingdom have also earned the distinction over multiple years, demonstrating a sustained commitment to employee experience. South Africa joins the list for the first time, reflecting the company’s continued progress as it expands its global footprint.
“As we continue to grow globally, sustaining a strong culture is essential to how we scale and perform,” said Gautam Thakkar, Chief Executive Officer, ResultsCX. “This recognition across eight countries reflects the consistency of our people practices, the strength of our leadership, and the accountability we bring to building an environment where teams can do their best work. A high-performing culture is not separate from business results. It is what enables them.”
With more than 24,000 colleagues across 23 global engagement hubs, maintaining a strong and consistent employee experience requires focus and discipline. ResultsCX has invested in leadership capability, career development, well-being initiatives, and inclusion programmes to help employees across regions feel supported, empowered, and aligned to shared values and business goals.
“Great Place To Work Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience,” said Sarah Lewis-Kulin, Vice President of Global Recognition at Great Place To Work. “Certification is the only official recognition based entirely on real-time employee feedback about company culture. By earning this recognition, ResultsCX has shown that it stands out as one of the top companies to work for, creating a workplace where employees can thrive.”
About ResultsCX
ResultsCX is a leading provider of transformational Customer Experience Management (CXM) solutions to 130+ global brands, including Fortune 100 and FTSE 250 companies. For 30+ years, we have been driving superior customer and business outcomes for brands across Healthcare, Media, Telecom, Fast Growth technology, Retail, Banking and Financial Services, and other industries globally.
Our award-winning approach helps brands prioritize investments and build digitally influenced customer journeys, creating high-value impact across three areas: Revenue Acceleration, Cost Optimization, and Enhanced Experience. Supported by 24,000+ colleagues and 23 engagement hubs worldwide, our innovative solutions and services solve persistent customer experience challenges, making life easier for millions of consumers. For more information about ResultsCX and its award-winning customer experience solutions, please visit www.resultscx.com.
ResultsCX is backed by ChrysCapital. Founded in 1999, ChrysCapital is one of the largest and most established investment firms investing in India, with ~ $8.5 billion raised across 10 private equity funds, a continuation fund, and a public markets fund. A highly experienced investor in the Enterprise Technology space, ChrysCapital has successfully invested in high-growth companies such as Infosys, Infogain, GeBBS HCL, Mphasis, LTI, Hexaware and Spectramind.
In the latest trading session, Duolingo, Inc. (DUOL - Free Report) closed at $123.39, marking a -3.65% move from the previous day. This change lagged the S&P 500's 1.22% loss on the day. Meanwhile, the Dow experienced a drop of 0.98%, and the technology-dominated Nasdaq saw a decrease of 1.35%.
Coming into today, shares of the company had gained 12.24% in the past month. In that same time, the Business Services sector gained 0.83%, while the S&P 500 gained 1.56%.
The investment community will be paying close attention to the earnings performance of Duolingo, Inc. in its upcoming release. In that report, analysts expect Duolingo, Inc. to post earnings of $0.62 per share. This would mark a year-over-year decline of 31.87%. Meanwhile, the latest consensus estimate predicts the revenue to be $296.19 million, indicating a 17.42% increase compared to the same quarter of the previous year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $2.84 per share and a revenue of $1.21 billion, indicating changes of -66.86% and +16.36%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Duolingo, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Right now, Duolingo, Inc. possesses a Zacks Rank of #4 (Sell).
From a valuation perspective, Duolingo, Inc. is currently exchanging hands at a Forward P/E ratio of 45.17. This denotes a premium relative to the industry average Forward P/E of 15.84.
We can additionally observe that DUOL currently boasts a PEG ratio of 0.97. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Technology Services industry currently had an average PEG ratio of 1.43 as of yesterday's close.
The Technology Services industry is part of the Business Services sector. With its current Zacks Industry Rank of 165, this industry ranks in the bottom 33% of all industries, numbering over 250.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
ONEOK (OKE) offers a compelling mix of acquisition-driven growth, aggressive CapEx, and a high, growing dividend yield. OKE's 76% natural gas/NGL focus positions it to benefit from surging AI Data Center demand, especially in the Permian Basin. OKE trades at a 10.5X EV/EBITDA, below peers, with potential for a 12.5X multiple and 19% upside if growth accompanied by deleveraging efforts continue.
AtriCure (ATRC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
On June 17, 2026, we present a DCF analysis for Edwards Lifesciences Corp EW . The company has shown a price performance of +1.2% over the past week, +8.8% over the past month, +3.9% year-to-date, and +18.4% over the past year. Here are some key points from our analysis:
DCF Earnings-based intrinsic value is $51.05, indicating a margin of safety of -73.5% compared to the current price of $88.58. DCF Free Cash Flow (FCF)-based intrinsic value is $21.50, suggesting a significantly overvalued status. GF Score™ of 97/100 indicates high reliability of the DCF inputs. What Is EW Worth? DCF Earnings-Based Model In our DCF earnings-based model, we assume a current EPS (TTM, excluding non-recurring items) of $2.70 and a 10-year earnings growth rate of 12.5%. The discount rate is calculated at 11%, based on the 10-Year Treasury Rate of 4.43% plus an equity risk premium of 6%. The terminal growth rate is set at 4% for years 11-20.
Parameter Value Current EPS (TTM, excl. non-recurring) $2.70 10-Year Growth Rate 12.5% 10-Year Treasury Rate 4.43% Discount Rate (ceil(Treasury) + 6%) 11% Terminal Growth Rate 4% Our two-stage model consists of a growth phase (Years 1-10) where EPS grows at 12.5% per year, discounted at 11%, and a terminal phase (Years 11-20) where growth slows to a 4% terminal rate, also discounted at 11%. Below is the calculation summary:
Stage Description Value Growth Stage (Years 1-10) EPS growing at 12.5%, discounted at 11% $29.09 Terminal Stage (Years 11-20) 4% terminal growth, discounted at 11% $21.96 Intrinsic Value Growth + Terminal $51.05 With the current price at $88.58, the intrinsic value of $51.05 indicates that the stock is modestly overvalued, with a margin of safety of -73.5%. It is important to note that GuruFocus uses EPS without non-recurring items because research shows stock prices correlate more closely with earnings than free cash flow. For further details, visit the EW DCF Calculator.
What Does the Free Cash Flow DCF Say? The free cash flow (FCF)-based intrinsic value for Edwards Lifesciences Corp is calculated at $21.50. When comparing this with the earnings-based intrinsic value of $51.05, the two models disagree significantly. The FCF model indicates that the stock is significantly overvalued, with a margin of safety of -312.0%.
How Does GF Value™ Compare to the DCF Models? The GF Value™ for Edwards Lifesciences Corp is $92.96, providing a third perspective on valuation. GF Value™ is GuruFocus' proprietary measure calculated from historical trading multiples, past business growth, and future performance estimates. While the DCF earnings model suggests modest overvaluation and the FCF model indicates significant overvaluation, the GF Value™ suggests that the stock is undervalued by 4.7%. This divergence among the three models highlights the complexity of valuation assessments. For more information, visit the GF Value™ page.
What Does EW's GF Score™ Tell Us? The GF Score™ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Score™ values have been found to generate higher long-term returns (backtested 2006-2021). Below is the breakdown of Edwards Lifesciences Corp's GF Score™:
Metric Rating GF Score™ 97/100 Financial Strength 9/10 Profitability 9/10 Growth 10/10 Valuation 10/10 Momentum 7/10 The predictability rank is 1/5 stars, indicating that higher predictability means the DCF model is less reliable for this stock. For more insights, visit the EW stock page.
Key Assumptions and Limitations It is essential to recognize that DCF models are highly sensitive to growth rate and discount rate assumptions. Stocks with low predictability ratings, such as Edwards Lifesciences Corp, produce less reliable DCF estimates. The terminal growth rate of 4% is a simplifying assumption that may not reflect future economic conditions.
What This Means for Investors In synthesizing the three valuation models—DCF earnings, DCF FCF, and GF Value™—we find a consensus indicating that Edwards Lifesciences Corp is overvalued. The earnings-based model suggests modest overvaluation, while the FCF model indicates significant overvaluation. However, the GF Value™ suggests a slight undervaluation. Overall, the clear verdict is that the stock appears to be overvalued at its current price. For the full DCF analysis, visit the EW DCF Calculator. You can also explore the GF Value™ page, or use the GuruFocus Stock Screener to find undervalued predictable companies.
Frequently Asked Questions What is EW's intrinsic value based on DCF?
Answer: earnings-based $51.05, FCF-based $21.50
Is EW overvalued or undervalued?
Answer: Based on the DCF and GF Value™ consensus, EW is overvalued.
How reliable is the DCF model for EW?
Answer: The predictability rank is 1/5, indicating lower reliability for the DCF model.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Green Thumb has surged 17.5% in three months as regulatory progress, Q1 growth and buybacks lift sentiment, but competition and pricing pressure persist.
HOUSTON--(BUSINESS WIRE)--Oceaneering International, Inc. (“Oceaneering”) (NYSE:OII) will report its second quarter 2026 financial results on Wednesday, July 22, 2026, after the close of trading on the New York Stock Exchange. Oceaneering will host a conference call and webcast to discuss the results on Thursday, July 23, 2026, at 10:00 a.m. Central Time (11:00 a.m. Eastern Time).
The earnings release and a link to the webcast will be posted on Oceaneering’s Investor Relations website.
Oceaneering is a global technology company delivering engineered services and products and robotic solutions to the offshore energy, defense, aerospace, and manufacturing industries.
For more information, please visit oceaneering.com.
HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Security division received an order for approximately $50 million from a North American customer to provide ongoing maintenance service for its installed base of Rapiscan® inspection systems that are utilized for screening baggage, cargo and vehicles. As part of the award, the Company is also expected to provide continued support for its CertScan® Platform.
OSI Systems’ President and CEO, Ajay Mehra, commented, "We are pleased to extend our long-standing support for this customer’s security operations. Our focus remains on delivering dependable service while enhancing performance and visibility across the installed base through CertScan."
About OSI Systems
OSI Systems designs and manufactures specialized electronic systems and components for critical applications. The Company operates through three business segments: Security, Optoelectronics and Manufacturing, and Healthcare. Its Security division delivers advanced inspection systems, turnkey screening solutions, and comprehensive support services to protect people and infrastructure. The Optoelectronics and Manufacturing segment serves as a global supplier of high-performance optoelectronic solutions and precision manufacturing services for leading OEMs. The Healthcare segment focuses on patient monitoring, diagnostic cardiology, and related services with the goal of enhancing clinical care and patient outcomes. Serving customers in over 170 countries, OSI Systems strategically positions its sales, service, R&D, and manufacturing capabilities worldwide to provide fast and efficient delivery and support. For more information on OSI Systems or any of its subsidiary companies, visit www.osi-systems.com. News Filter: OSIS-G
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to OSI Systems’ current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside OSI Systems’ control and which may cause actual results to differ materially from those described in or implied by any forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are based on currently available information and speak only as of the date on which they are made. OSI Systems assumes no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information, or otherwise, except to the extent it is required to do so in connection with its ongoing requirements under Federal securities laws. For a further discussion of factors that could cause OSI Systems’ future results to differ materially from any forward-looking statements, see the section entitled "Risk Factors" in OSI Systems’ most recently filed Annual Report on Form 10-K and other risks described therein and in documents subsequently filed by OSI Systems from time to time with the Securities and Exchange Commission.
